形状积分作为人类癌症的驱动因素
Eran Sdeor1, Hajime Okada1, Ron Saad1,2
1Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Nature genetics
|October 2, 2024
概括
状体,一个异常的染色体数量,驱动癌症的发展,并影响治疗结果. 研究人员正在确定导致复发性形形状的特定基因,以开发向癌症疗法.
科学领域:
- 癌症遗传学 癌症遗传学
- 基因组学就是基因组学.
- 分子瘤学分子瘤学
背景情况:
- 体积,一个异常的染色体数,是人类癌症的一个公认的标志.
- 它作为癌症发展和进展的驱动因素的确切作用在很大程度上仍未确定.
- 形形状显著影响患者对癌症治疗的反应和整体临床结果.
研究的目的:
- 审查复发性动脉和它们在驱动瘤发展中的作用.
- 探索驱动基因的上下文依赖的识别和功能性特征,这些基因是形化病的基础.
- 通过癌症基因组学和模型研究发现驱动基因的策略.
- 讨论在癌症治疗中准驱动性形瘤的机会.
主要方法:
- 审查现有的关于复发性动脉瘤和癌症遗传学的文献.
- 分析癌症基因组学数据以确定驱动基因.
- 利用癌症模型来进行形状的功能性表征.
- 探索治疗策略,以化的后果为目标.
主要成果:
- 复发性动脉是瘤发展的重要驱动因素.
- 在常见的形形状病的基础上,特定的遗传元素很难识别.
- 新兴的策略利用基因组学和模型来发现驱动基因.
- 针对驱动器形状的功能后果提供了治疗机会.
结论:
- 积体是癌症发病,进展和治疗反应的关键因素.
- 识别复发性动脉瘤的驱动基因对于理解癌症遗传学至关重要.
- 新型基因组和建模方法正在推动这些驱动基因的发现.
- 形形状瘤的向为未来的癌症治疗提供了一个有希望的途径.
相关概念视频
Nondisjunction
3.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K


